...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR

All the Pharma boys looking thru BET window for certain now . Is this data as good as it appears ? More importantly tox profile looks best in class as well.

 

5
Mar 31, 2019 08:05AM
2
Apr 01, 2019 02:39PM
1
Apr 01, 2019 05:52PM
3
Apr 01, 2019 05:58PM
2
Apr 01, 2019 08:25PM
8
Apr 08, 2019 11:46AM
2
Apr 09, 2019 11:36AM
Share
New Message
Please login to post a reply